FDA approves Bristol Myers Squibb's schizophrenia drug
Bristol Myers Squibb's Cobenfy drug Courtesy: Bristol Myers Squibb The Food and Drug Administration on Thursday approved Bristol-Myers SquibbCobenfy, the…
health care industry
Novo Nordisk's Ozempic may reduce risk of opioid overdose, study finds
A box of Ozempic manufactured by Novo Nordisk is seen at a pharmacy in London, Britain, March 8, 2024. Hollie…
Brett Favre tells Congress he's been diagnosed with Parkinson's
Former NFL quarterback Brett Favre testifies before the House Ways and Means Committee in the Longworth House Office Building on…
Wegovy could face upcoming Medicare drug price negotiations
Boxes of Ozempic and Wegovy manufactured by Novo Nordisk are seen in a pharmacy in London, Britain, March 8, 2024.…
Novo Nordisk CEO to testify before Senate on weight loss drug prices
Lars Fruergaard Jørgensen, CEO of Novo Nordisk, speaks during an interview in New York on August 10, 2022. Christopher Goodney…
Why Eli Lilly and Palo Alto Networks are keeping up with their competitors
Every weekday, the CNBC Investment Club with Jim Cramer publishes Homestretch, a handy evening update, just in time for the…
FTC sues drug brokers for allegedly inflating insulin prices
Federal Trade Commission (FTC) Chair Lina Khan testifies before the House Appropriations Subcommittee in the Rayburn House Office Building on…
Why disputing a medical bill can help reduce your costs
Consumers may feel like their medical bills are inflexible, unyielding, unmovable. But that's not always the case: A new study…
Novartis CEO says it won't join weight-loss drug frenzy
The CEO of Novartis The Swiss pharmaceutical giant has no intention of getting into the “frenzy” of weight loss drugs,…
23andMe Independent Directors Resign From Board: Read CEO Memo
Anne Wojcicki, co-founder and CEO of 23andme Inc., speaks during the South by Southwest (SXSW) festival in Austin, Texas, U.S.,…